Immunity biochemist James Chen scoops Lasker Award
Zhijian ‘James’ Chen, Professor of Molecular Biology and Director of the Center for Inflammation Research at UT Southwestern Medical Center, has been awarded the Albert Lasker Basic Medical Research Award for his discovery of the cGAS enzyme, which senses invading pathogens and triggers the body’s innate immune system.
The Lasker Awards recognise significant advances in the understanding, diagnosis, treatment, cure, and prevention of human disease and are regarded as the country’s preeminent biomedical research prize.
“Dr Chen’s research has elucidated the process by which our bodies fight off invasive pathogens, including viruses, bacteria, and other microbes, through the detection of wayward intracellular nucleic acids. Insights into this signalling pathway provide a foundation for new approaches to the treatment of cancer and autoimmune diseases as well as vaccine development,” said Daniel Podolsky, President of UT Southwestern.
Dr Chen’s discoveries include MAVS, the first mitochondrial protein known to be involved in immunity against infections. The protein’s name describes its function (mitochondrial antiviral signalling) and honours his favourite basketball team, the Dallas Mavericks.
More recently, he identified cGAS (cyclic GMP-AMP synthase), which senses foreign DNA in a cell’s interior, or cytoplasm. It then activates STING (stimulator of interferon genes) and triggers an inflammatory response, including the production of type 1 interferons, essential for combatting infections and regulating immune responses.
Dr Chen was also announced as a recipient of the Paul Ehrlich and Ludwig Darmstaedter Prize, Germany’s highest honour in the field of medicine. He shares the prize with Glen Barber, Professor of Surgery and Chair of the Center of Innate Immunity and Inflammation at The Ohio State University, and Andrea Ablasser, Professor of Food Science at EPFL, the École polytechnique fédérale de Lausanne in Switzerland, for their work on innate immunity.
